NCT02714699View on ClinicalTrials.gov

Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

May 31, 2017

Conditions
Endoscopy
Interventions
DRUG

diclofenac potassium

patients will take oral diclofenac potassium; two tablets (cataflam 25 mg) and one tablet placebo one hour before the procedure

DRUG

hyoscine butyl bromide

patients will take oral hyoscine-N- butyl bromide; 2 tablets (buscopan 10 mg) one hour before the procedure

DRUG

placebo

patients will take oral placebo; 2 tablets one hour before the procedure

Trial Locations (1)

002

Ahmed Abbas, Assiut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02714699 - Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy | Biotech Hunter | Biotech Hunter